The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 316-319

  Jemaa, Zeineb ^a   Kallel, Amani ^a   Sleimi, Chaker ^a   Mahjoubi, Imen ^a   Feki, Moncef ^a   Ftouhi, Bochra ^a   Slimane, Hedia ^a   Jemaa, Riadh ^a   Kaabachi, Naziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Diabetes; PCR RFLP; Polymorphism; PPARGC1A

Indexed keywords

BIOLOGICAL MARKER; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; CASE CONTROL STUDY; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TRANSCRIPTION FACTORS; TUNISIA;

EID: 84887343641     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.10.011     Document Type: Article

References (31)

1. J. Rhee, Y. Inoue, J.C. Yoon, P. Puigserver, M. Fan, F.J. Gonzalez, and et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1) requirement for hepatocyte nuclear factor 4 alpha in gluconeogenesis Proc Natl Acad Sci USA 100 2003 4012 4017
2. Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, and et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98 1999 115 124
3. J. Lin, P.T. Tarr, R. Yang, J. Rhee, P.P. Puigserver, C.B. Newgard, and et al. PGC-1 beta in the regulation of hepatic glucose and energy metabolism J Biol Chem 278 2003 30843 30848
4. H. Esterbauer, H. Oberkofler, F. Krempler, and W. Patsch Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression Genomics 62 1999 98 102
5. L. Perusse, T. Rice, Y.C. Chagnon, J.P. Després, S. Lemieux, S. Roy, and et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family study Diabetes 50 2001 614 621
6. R.E. Pratley, D.B. Thompson, M. Prochazka, L. Baier, D. Mott, E. Ravussin, and et al. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians J Clin Invest 101 1998 1757 1764
7. H. Allayee, T.W. de Bruin, K. Michelle Dominguez, L.S. Chen, E. Ipp, R.M. Cantor, and et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p Hypertension 38 2001 773 778
8. K. Hara, K. Tobe, T. Okada, H. Kadowaki, Y. Akanuma, C. Ito, and et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes Diabetologia 45 2002 740 743
9. H. Esterbauer, H. Oberkofler, V. Linnemayr, B. Iglseder, M. Hedegger, P. Wolfsgruber, and et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: association with obesity indices in middle-aged women Diabetes 51 2002 1281 1286
10. Y.L. Muller, C. Bogardus, O. Pedersen, and L. Baier A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians Diabetes 52 2003 895 898
11. J.A. Levine, N.L. Eberhardt, and M.D. Jensen Role of nonexercise activity thermogenesis in resistance to fat gain in humans Science 283 1999 212 214
12. J. Ek, G. Andersen, S.A. Urhammer, P.H. Gaede, T. Drivsholm, K. Borch-Hohnsen, and et al. Mutation analysis of peroxisome proliferator-activated receptoe-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type 2 diabetes mellitus Diabetologia 44 2001 2220 2226
13. G. Andersen, T. Hansen, N. Gharani, T.M. Fraiyling, K.R. Owen, M. Sampson, and et al. A common Gly482Ser polymorphism of PGC-1 is associated with type 2 diabetes mellitus in two European populations Diabetes 51 2002 A49 A50
14. T. Kunej, M.G. Petrovic, P. Dovc, B. Peterlin, and D. Petrovic A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians Folia Biol 50 2004 157 158
15. K.S. Vimaleswaran, V. Radha, S. Ghosh, P.P. Majumder, R. Deepa, H.N.S. Babu, and et al. Peroxisome proliferator-activated receptor-gamma co-activator-alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians Diabet Med 22 2005 1516 1521
16. C. Lacquemant, M. Chikri, P. Boutin, C. Samson, and P. Froguel No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians Diabetologia 45 2002 602 603
17. I. Barroso, J. Luan, R.P.S. Middelberg, A.H. Harding, P.W. Franks, R.W. Jakes, and et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action PLoS Biol 1 2003 41 55
18. K.G.M.M. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet Med 15 1998 539 553
19. World Health Organization Physical status: the use and interpretation anthropometry: report of a WHO Expert Committee, WHO Technical Report Series, no. 854 1995 WHO Genova 321 344
20. W.T. Friedwald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
21. A. Marcadet, P. O'Connel, and D. Cohen Standardized Southern blot workshop techniques B. Dupont, Histocompatibility testing 1987 Springer New York 587 590
22. M.C. Hsieh, K.D. Lin, K.J. Tien, S.T. Tu, J.Y. Hsiao, S.J. Chang, and et al. Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus Met Clin Exp 59 2010 1139 1144
23. A. Bhat, A. Koul, E. Rai, S. Sharma, M.K. Dhar, R.N. Bamezai, and et al. PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study Hum Genet 121 2007 609 614
24. I. Barroso, J. Luan, M.S. Sandhu, P.W. Franks, V. Crowley, A.J. Schafer, and et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes Diabetologia 49 2006 501 505
25. Y. Yang, X. Mo, S. Chen, X. Lu, and D. Gu Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis Diabetes Metab Res Rev 27 2011 177 184
26. S. Chen, W. Yan, J. Huang, W. Yang, and D. Gu Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha polymorphism is not associated with essential hypertension and type 2 diabetes mellitus in Chinese population Hypertens Res 27 2004 813 820
27. S. Zhu, Y. Liu, X. Wang, X. Wu, X. Zhu, J. Li, and et al. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population Diabetes Res Clin Pract 86 2009 168 172
28. M.C. Vohl, A. Houde, S. Lebel, F.S. Hould, and P. Marceau Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome Mol Genet Metab 86 2005 300 306
29. L. Andrulionyte, J. Zacharova, J.L. Chiasson, and M. Laakso Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial Diabetologia 47 2004 2176 2184
30. 2max Med Sci Sports Exerc 35 2003 1998 2004
31. A. Lucia, F. Gomez-Gallego, and I. Barroso PPARGC1 genotype (Gly482Ser) predicts exceptional endurance capacity in European males J Appl Phisiol 99 2005 344 348